[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100360479":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":19,"locations":29,"responsibleParty":51,"collaborators":53,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":58,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"UC patients",null,"Patients diagnosed with primary or recurrent non-muscle-invasive bladder (NMIBC) cancer.\n\nNo experimental intervention will be administered. NMIBC patients will be diagnosed, treated and followed up according to guidelines-based institutional routines.\n\nThe clinical (demographic, operative and follow-up) and pathological data of the patients will be collected in a complete anonymous way.",[13,17],{"name":14,"affiliation":15,"role":16},"Steven Joniau, MD, PhD","Assistant Professor","PRINCIPAL_INVESTIGATOR",{"name":18,"affiliation":15,"role":16},"Frank Van Der Aa, MD, PhD",[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Murat Akand, MD","CONTACT","+3216346687","murat.akand@uzleuven.be",{"name":26,"role":22,"phone":27,"phoneExt":10,"email":28},"Tim Muilwijk, MD","+3216346104","tim.muilwijk@uzleuven.be",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"University Hospitals Leuven","RECRUITING","Leuven","Vlaams-Brabant","3000","Belgium","BE",{"type":39,"coordinates":40},"Point",[41,42],4.70093,50.87959,{"lat":42,"lon":41},[45,46,47,48,50],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"name":14,"role":16,"phone":10,"phoneExt":10,"email":10},{"name":18,"role":16,"phone":10,"phoneExt":10,"email":10},{"name":21,"role":49,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"name":26,"role":49,"phone":10,"phoneExt":10,"email":10},{"type":52,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[54],{"name":55,"class":6},"KU Leuven","100360479","prospective-sample-collection-for-cancer-of-bladder-100360479",false,"NCT03973671","Prospective Sample Collection for Cancer of Bladder","Flemish Prospective Clinical and Pathological Database for Urothelial Cancer","ProCaB","Inclusion Criteria:\n\n* who are aged between 18-90,\n* who are of male or female sex,\n* who give their informed consent to collect their clinical and pathological data,\n* who are planned to undergo TURBT for BC,\n* who are planned to undergo (salvage) radical cystectomy with or without an extended pelvic lymph node dissection,\n* who are planned to undergo tumor biopsy (from primary or metastatic tumor),\n* who are planned to undergo radical nephroureterectomy ± partial cystectomy or segmental ureterectomy, with or without a lymph node dissection,\n* who are planned to undergo endoscopic tumor biopsy or resection,\n* from whom metastases will be surgically removed.\n\nExclusion Criteria:\n\n* patients who do not give their informed consent to collect their clinical and pathological data,\n* patients who withdraw their informed consent to use their clinical and pathological data,\n* patients who refuse the planned treatment,\n* women who are pregnant or have suspicion of pregnancy.","ALL","18 Years","90 Years",{"count":68,"type":69},300,"ESTIMATED","OBSERVATIONAL","The goal of the Flemish Databank for Urothelial Cancer is to collect clinical and pathological data of patients treated for urothelial cancer (UC).",[73],"Urinary Bladder Neoplasms",[75,76,77,78,79],"Risk stratification","Recurrence","Progression","Non-muscle-invasive bladder cancer","Muscle-invasive bladder cancer","2024-03-26",{"date":82,"type":83},"2024-03-28","ACTUAL",{"date":85,"type":83},"2020-05-29",{"date":87,"type":69},"2032-05",{"name":5,"class":6},1]